FDA clears Neurotronics' AI-based sleep analysis software
Neurotronics received FDA clearance for its AI-based sleep analysis software on 4 November. MobiHealthNews reported the decision.
Who is affected and how
- doctor
- Automating the analysis used in sleep diagnostics may partly replace manual scoring, but clinical validation is still required.
- medtech company
- Another 510(k)-type reference for the regulatory pathway of AI-based software products.
Sources
- Neurotronics receives FDA clearance for AI sleep analysis software - MobiHealthNewsmobihealthnews.com · Nov 4, 2026
- PulseAI Receives U.S. FDA 510(k) Clearance of AI-Powered Arrhythmia Analysis Model for Wearablesprnewswire.com · Nov 5, 2026
- PulseAI says its wearable ECG analysis model received FDA clearanceruntimewire.com · Nov 5, 2026
- PulseAI Receives FDA 510(k) Clearance For Its AI-powered Arrhythmia Analysis Technology, Advancing Cardiac Monitoring Capabilities In Wearable Device - Medical Device News Magazineinfomeddnews.com · Nov 5, 2026
- PulseAI Wins FDA Nod for AI Wearable Arrhythmia Analysismedical product outsourcing · Nov 6, 2026
- PulseAI’s arrhythmia analysis model for wearables lands FDA clearancemedicaldevice-network.com · Nov 6, 2026
- PulseAI Receives FDA 510(k) Clearance for AI-Powered Arrhythmia Analysis Model for Wearables - News Centerg-medtech.com · Nov 6, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.